Terns Pharmaceuticals, Inc.: insider trades · United States · SEC (Form 4)

Discover the full directors' dealings record of Terns Pharmaceuticals, Inc., a listed issuer based in United States. Shares are quoted on US US, under the oversight of SEC (Form 4). Operating in the Technology sector, Terns Pharmaceuticals, Inc. has logged 3 public disclosures. Market capitalisation: €777.4bn. The latest transaction was disclosed on 8 June 2022 (Acquisition). Among the most active insiders: Yoon Seokho Bryan. All data is openly available.